{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:35:50Z","timestamp":1791894950185,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016168","name":"Ludwig Boltzmann Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128467","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:52:43Z","timestamp":1774522363000},"page":"128467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2"],"prefix":"10.1016","volume":"79","author":[{"given":"Alina","family":"Tscherne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128467_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0042-6822(78)90153-8","article-title":"On the origin of the human influenza virus subtypes H2N2 and H3N2","volume":"87","author":"Scholtissek","year":"1978","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0010","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/jvi.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0015","first-page":"455","article-title":"Studies in swine of Asian influenza virus","volume":"20","author":"Wallace","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0020","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1073\/pnas.0904991106","article-title":"Dating the emergence of pandemic influenza viruses","volume":"106","author":"Smith","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0025","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/JVI.02590-14","article-title":"Adaptation of pandemic H2N2 influenza A viruses in humans","volume":"89","author":"Joseph","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0045","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.1958.02990100028006","article-title":"Pandemic influenza in 1957; review of international spread of new Asian strain","volume":"166","author":"Dunn","year":"1958","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0100","first-page":"489","article-title":"The 1957 influenza pandemic in the USSR","volume":"20","author":"Zhdanov","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0105","first-page":"34","article-title":"Asian influenza in the United States, 1957-1958","volume":"70","author":"Trotter","year":"1959","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2026.128467_bb0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2105\/AJPH.2019.305557","article-title":"Fifty years of influenza A(H3N2) following the pandemic of 1968","volume":"110","author":"Jester","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2026.128467_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac009","article-title":"Transmission dynamics of low pathogenicity avian influenza (H2N2) viruses in live bird markets of the Northeast United States of America, 2013-2019","volume":"8","author":"Chung","year":"2022","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0040","first-page":"1016","article-title":"Asian influenza in Great Britain 1957-58","volume":"51","author":"Mc","year":"1958","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0050","first-page":"187","article-title":"Summary report on the Asian influenza epidemic in Japan, 1957","volume":"20","author":"Fukumi","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/4590056","article-title":"Administrative history of the Asian influenza program","volume":"73","author":"Stewart","year":"1958","journal-title":"Public Health Rep (1896)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2307\/4590057","article-title":"Asian influenza surveillance","volume":"73","author":"Langmuir","year":"1958","journal-title":"Public Health Rep (1896)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2307\/4590246","article-title":"Mortality in the 1957-58 influenza epidemic","volume":"73","author":"Dauer","year":"1958","journal-title":"Public Health Rep (1896)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0070","first-page":"401","article-title":"Experience with influenza vaccination in Iceland, 1957","volume":"20","author":"Sigurjonsson","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0075","first-page":"148","article-title":"Morbidity and mortality characteristics of Asian strain influenza","volume":"75","author":"Chin","year":"1960","journal-title":"Public Health Rep (1896)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.1.5065.259","article-title":"Influenza A (Asian) 1957; clinical and epidemiological features in a general practice","volume":"1","author":"Fry","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0085","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.1960.03020120001001","article-title":"Monovalent Asian influenza vaccine: evaluation of its use during two waves of epidemic Asian influenza in partly immunized penitentiary population","volume":"172","author":"Dull","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0090","first-page":"310","article-title":"Influenza virus vaccine. The effect upon an outbreak of the disease among a geriatric population","volume":"99","author":"Krag","year":"1963","journal-title":"Calif Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI103789","article-title":"Studies on influenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy","volume":"38","author":"Blumenfeld","year":"1959","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2026.128467_bb0110","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/infdis\/jiv534","article-title":"Global mortality impact of the 1957-1959 influenza pandemic","volume":"213","author":"Viboud","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918-1920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0120","first-page":"4","article-title":"The geography and mortality of the 1918 influenza pandemic","volume":"65","author":"Patterson","year":"1991","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(58)90006-0","article-title":"Psychosis following Asian influenza in Barbados","volume":"2","author":"Still","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2307\/4591383","article-title":"Influenza surveillance, United States, 1960","volume":"76","author":"Eickhoff","year":"1961","journal-title":"Public Health Reports (1896-1970)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0135","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bmj.1.5284.1042","article-title":"Inactivated influenza vaccine in an industrial undertaking","volume":"1","author":"Fortuin","year":"1962","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0140","first-page":"253","article-title":"Influenza viruses, 1957-60","volume":"26","author":"Isaacs","year":"1962","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3181\/00379727-114-28692","article-title":"Antigenic relationship of 1961-1963 A2 influenza viruses to prototype A2 1957 strain","volume":"114","author":"Morris","year":"1963","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01907-18","article-title":"The molecular basis for antigenic drift of human a\/H2N2 influenza viruses","volume":"93","author":"Linster","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0155","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001881","article-title":"Continued adaptation of A\/H2N2 viruses during pandemic circulation in humans","volume":"104","author":"Kutter","year":"2023","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011158","article-title":"Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957","volume":"5","author":"Pappas","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128467_bb0165","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1038\/s41467-024-54374-z","article-title":"Dual receptor-binding, infectivity, and transmissibility of an emerging H2N2 low pathogenicity avian influenza virus","volume":"15","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128467_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/v11110978","article-title":"Antigenic change in human influenza a(H2N2) viruses detected by using human plasma from aged and younger adult individuals","volume":"11","author":"Matsuzawa","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128467_bb0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128467_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virol.2004.06.009","article-title":"Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events","volume":"328","author":"Lindstrom","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0185","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jmb.2005.11.002","article-title":"Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities","volume":"355","author":"Stevens","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/viro.1994.1615","article-title":"Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates","volume":"205","author":"Connor","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0195","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1128\/JVI.74.18.8502-8512.2000","article-title":"Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals","volume":"74","author":"Matrosovich","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0200","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/JVI.02162-09","article-title":"Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic","volume":"84","author":"Xu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013768","article-title":"Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin","volume":"5","author":"Viswanathan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128467_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14745\/ccdr.v51i04a04","article-title":"A rapid review of the avian influenza PB2 E627K mutation in human infection studies","volume":"51","author":"MacCosham","year":"2025","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2026.128467_bb0215","article-title":"Mouse-adapted H9N2 influenza A virus PB2 protein M147L and E627K mutations are critical for high virulence","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128467_bb0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.virol.2014.08.010","article-title":"PB2-E627K and PA-T97I substitutions enhance polymerase activity and confer a virulent phenotype to an H6N1 avian influenza virus in mice","volume":"468-470","author":"Cheng","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature16474","article-title":"Species difference in ANP32A underlies influenza A virus polymerase host restriction","volume":"529","author":"Long","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128467_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0042-6822(91)90003-T","article-title":"The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity","volume":"180","author":"Baum","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49884-9","article-title":"A(H2N2) and a(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases","volume":"15","author":"Liang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128467_bb0250","first-page":"535","article-title":"Antibodies to human influenzavirus neuraminidase (the A-Asian-57 H2N2 strain) in sera from Australian pelagic birds","volume":"47","author":"Laver","year":"1972","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0255","first-page":"820","article-title":"Influenza A virus recycling revisited","volume":"77","author":"Dowdle","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0260","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(58)91739-2","article-title":"Serological studies with Asian strain of influenza A","volume":"1","author":"Clarke","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0265","first-page":"461","article-title":"Serological characteristics of a \u201cnew\u201d serotype of influenza A virus: the Hong Kong strain","volume":"41","author":"Masurel","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0270","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(58)91738-0","article-title":"Pre-epidemic antibody against 1957 strain of Asiatic influenza in serum of older people living in the Netherlands","volume":"1","author":"Mulder","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0275","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0042-6822(75)90453-5","article-title":"Studies on the origin of pandemic influenza viruses V. Persistence of Asian influenza virus hemagglutinin (H2) antigen in nature?","volume":"67","author":"Webster","year":"1975","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0280","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JVI.02526-13","article-title":"Risk assessment of H2N2 influenza viruses from the avian reservoir","volume":"88","author":"Jones","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0285","doi-asserted-by":"crossref","first-page":"20949","DOI":"10.1073\/pnas.0710286104","article-title":"Identification of H2N3 influenza a viruses from swine in the United States","volume":"104","author":"Ma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0290","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1292\/jvms.17-0048","article-title":"Genetic characterization of an H2N2 influenza virus isolated from a muskrat in Western Siberia","volume":"79","author":"Gulyaeva","year":"2017","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2026.128467_bb0295","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/infdis\/jiy291","article-title":"Population serologic immunity to human and avian H2N2 viruses in the United States and Hong Kong for pandemic risk assessment","volume":"218","author":"Babu","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.02.004","article-title":"Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later","volume":"58","author":"Spangler","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128467_bb0305","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.07158-11","article-title":"Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses","volume":"86","author":"Krause","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jiv407","article-title":"Serum samples from middle-aged adults vaccinated annually with seasonal influenza vaccines Cross-neutralize some potential pandemic influenza viruses","volume":"213","author":"Wang","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41591-021-01636-8","article-title":"A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0320","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.vaccine.2021.05.064","article-title":"Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans","volume":"39","author":"Beau Reneer","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128467_bb0705","unstructured":"PopulationPyramid.net. Population Pyramids of the World from 1950 to 2100. Accessed October 26, 2025. https:\/\/www.populationpyramid.net\/world\/2025\/."},{"key":"10.1016\/j.vaccine.2026.128467_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128467_bb0335","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128467_bb0340","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0345","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128467_bb0350","doi-asserted-by":"crossref","unstructured":"Wang X, Kong H, Chu B, Yang Q, Lin C, Liu R, et al. Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells. Cell Host Microbe 2025;33:151\u201366 e8.","DOI":"10.1016\/j.chom.2024.12.004"},{"key":"10.1016\/j.vaccine.2026.128467_bb0355","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu115","article-title":"Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel","volume":"2","author":"Laguio-Vila","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.10.005","article-title":"Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase","volume":"56","author":"Lei","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128467_bb0365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128467_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/431150","article-title":"Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic","volume":"192","author":"Viboud","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128467_bb0380","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s42003-020-01278-5","article-title":"Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets","volume":"3","author":"van de Ven","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0385","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","article-title":"Human cytotoxic T-lymphocyte repertoire to influenza A viruses","volume":"72","author":"Jameson","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0390","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.06325-11","article-title":"A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus","volume":"86","author":"Babon","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0395","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-022-02429-7","article-title":"Investigation of CD4 and CD8 T cell-mediated protection against influenza a virus in a cohort study","volume":"20","author":"Tsang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0400","doi-asserted-by":"crossref","unstructured":"Dong W, Bhide Y, Sicca F, Meijerhof T, Guilfoyle K, Engelhardt OG, et al. Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines. Front Immunol 2018;9:2312.","DOI":"10.3389\/fimmu.2018.02312"},{"key":"10.1016\/j.vaccine.2026.128467_bb0405","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2010.12.073","article-title":"CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses","volume":"29","author":"Scheible","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128467_bb0410","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(57)92272-9","article-title":"The characteristics of influenza-virus strains isolated in 1957","volume":"273","author":"Zhdanov","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2307\/4590060","article-title":"Influenza vaccine","volume":"73","author":"Smadel","year":"1958","journal-title":"Public Health Reports (1896-1970)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0420","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/4590070","article-title":"Research programs on Asian influenza","volume":"73","author":"Andrews","year":"1958","journal-title":"Public Health Reports (1896-1970)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0425","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM195809252591304","article-title":"Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes","volume":"259","author":"Mc","year":"1958","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0430","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.1957.72980310001010","article-title":"Subcutaneous and intradermal vaccination with Asian influenza vaccine","volume":"165","author":"Boger","year":"1957","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0435","first-page":"14","article-title":"Asian influenza: a study of 150 persons during the 1957 pandemic","volume":"31","author":"Buebendorf","year":"1958","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0440","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.1957.02980290006002","article-title":"Artificially induced Asian influenza in vaccinated and unvaccinated volunteers","volume":"165","author":"Bell","year":"1957","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2105\/AJPH.52.2.275","article-title":"Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of navy recruits. II","volume":"52","author":"Stille","year":"1962","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2026.128467_bb0450","first-page":"355","article-title":"Human vaccination experiments with Asian influenza vaccine in Japan","volume":"20","author":"Fukumi","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0455","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(58)91741-0","article-title":"A serological trial of ASIAN-influenza vaccine after the AUTUMN epidemic","volume":"271","author":"Holland","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0460","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.2.5404.267","article-title":"Clinical trials of oil-adjuvant influenza vaccines, 1960-3. Report to the Medical Research Council by its Committee on influenza and other respiratory virus vaccines","volume":"2","author":"Ujhazy","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0465","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.2.5404.271","article-title":"Serological studies on adult volunteers inoculated with oil-adjuvant ASIAN influenza vaccine. Report to the M.R.C. Committee on influenza and other respiratory virus vaccines","volume":"2","author":"Hobson","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0470","first-page":"63","article-title":"Serologic response of atomic bomb survivors following Asian influenza vaccination","volume":"29","author":"Morita","year":"1966","journal-title":"Sapporo Igaku Zasshi"},{"key":"10.1016\/j.vaccine.2026.128467_bb0475","unstructured":"David J. Sencer CDC Museum. The First U.S. National Vaccination Campaign Launches. Accessed October 26, 2025. https:\/\/cdcmuseum.org\/exhibits\/show\/influenza\/1957-pandemic\/vaccine-rollout."},{"key":"10.1016\/j.vaccine.2026.128467_bb0480","unstructured":"David J. Sencer CDC Museum. Reviewing the 1957 Influenza Pandemic. Accessed October 26, 2025. https:\/\/cdcmuseum.org\/exhibits\/show\/influenza\/1957-pandemic\/reviewing-1957-pandemic."},{"key":"10.1016\/j.vaccine.2026.128467_bb0485","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.vaccine.2008.06.042","article-title":"History of influenza vaccination programs in Japan","volume":"26","author":"Hirota","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128467_bb0490","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bmj.2.5157.905","volume":"2","year":"1959","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0495","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/bmj.1.5068.459-b","article-title":"Influenza Vaccination","volume":"1","author":"Jhaveri","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0500","first-page":"301","article-title":"Influenza vaccine, Asian strain; reactions following its use in adults","volume":"87","author":"Sadusk","year":"1957","journal-title":"Calif Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0505","first-page":"888","article-title":"Evaluation of Asian influenza vaccine in an industrial population","volume":"79","author":"Nelson","year":"1958","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0510","first-page":"377","article-title":"Serological and prophylactic trials of Asian influenza vaccines in Sweden, 1957","volume":"20","author":"Heller","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0515","first-page":"497","article-title":"An assessment of oil adjuvant and aqueous influenza vaccines. II. Antibody responses to the vaccines","volume":"65","author":"Forsyth","year":"1967","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0520","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2307\/4591160","article-title":"Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule","volume":"76","author":"Hennessy","year":"1961","journal-title":"Public Health Rep (1896)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0525","first-page":"237","article-title":"Effectiveness of monovalent influenza A-prime vaccine during 1957 influenza A-prime epidemic","volume":"67","author":"Meiklejohn","year":"1958","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2026.128467_bb0530","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/bmj.2.5414.943","article-title":"Polyvalent Influenza Vaccine in General Practice","volume":"2","author":"Blow","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0535","first-page":"97","article-title":"Field trials of adjuvant and saline influenza vaccines","volume":"19","author":"Herbert","year":"1965","journal-title":"Br J Prev Soc Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0540","first-page":"856","article-title":"Inactivated polyvalent influenza virus vaccine--a controlled study of its efficacy in the prevention of respiratory illness in industrial workers","volume":"41","author":"Newman","year":"1967","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0545","first-page":"830","article-title":"Effectiveness of polyvalent influenza vaccine in pregnancy. Report of a controlled study during an outbreak of Asian influenza","volume":"23","author":"Hulka","year":"1964","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0550","first-page":"34","article-title":"Polyvalent influenza vaccine: comparison of jet injection with intradermal and subcutaneous syringe methods of administration","volume":"66","author":"Clark","year":"1965","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0555","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(57)90021-1","article-title":"Infection of volunteers with Asian influenza virus","volume":"273","author":"Isaacs","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0560","first-page":"581","article-title":"Some studies on the selection and efficiency of live influenza vaccine viruses","volume":"41","author":"Tyrrell","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0565","first-page":"261","article-title":"Results of further research on influenza in the USSR with special reference to the 1957 pandemic","volume":"20","author":"Zhdanov","year":"1959","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0570","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.4.5629.482","article-title":"Investigetion into the attenuation of influenza viruses by serial passage","volume":"4","author":"Beare","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2026.128467_bb0575","first-page":"599","article-title":"Evaluation of influenza virus mutants for possible use in a live virus vaccine","volume":"41","author":"Mills","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128467_bb0580","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s007050070109","article-title":"Cross-protection and reassortment studies with avian H2 influenza viruses","volume":"145","author":"Kaverin","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0585","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1292\/jvms.17-0312","article-title":"Potency of an inactivated influenza vaccine prepared from A\/duck\/Hokkaido\/162\/2013 (H2N1) against a challenge with A\/swine\/Missouri\/2124514\/2006 (H2N3) in mice","volume":"79","author":"Suzuki","year":"2017","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2026.128467_bb0590","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","author":"Hehme","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2026.128467_bb0595","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00430-002-0147-9","article-title":"Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines","volume":"191","author":"Hehme","year":"2002","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0600","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.vaccine.2017.01.026","article-title":"Evaluation of multivalent H2 influenza pandemic vaccines in mice","volume":"35","author":"Lenny","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128467_bb0605","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1128\/JVI.01829-13","article-title":"Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets","volume":"88","author":"Chen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102339","article-title":"Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus","volume":"9","author":"Isakova-Sivak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128467_bb0615","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01526-20","article-title":"Computationally optimized broadly reactive H2 HA influenza vaccines elicited broadly Cross-reactive antibodies and protected mice from viral challenges","volume":"95","author":"Reneer","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0620","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","article-title":"Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial","volume":"28","author":"Houser","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128467_bb0625","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41589-023-01529-6","article-title":"Vaccine design via antigen reorientation","volume":"20","author":"Xu","year":"2024","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0630","article-title":"Adenoviral-vectored centralized consensus hemagglutinin vaccine provides broad protection against H2 influenza a virus","volume":"10","author":"Petro-Turnquist","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128467_bb0645","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-2659.2012.00350.x","article-title":"An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults","volume":"7","author":"Talaat","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.128467_bb0650","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/21645515.2015.1010859","article-title":"H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers","volume":"11","author":"Isakova-Sivak","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128467_bb0635","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees c","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128467_bb0640","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.virol.2009.12.003","article-title":"Safety, immunogencity, and efficacy of a cold-adapted A\/Ann Arbor\/6\/60 (H2N2) vaccine in mice and ferrets","volume":"398","author":"Chen","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128467_bb0655","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2026.128467_bb0660","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128467_bb0665","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3399\/bjgp09X453882","article-title":"History lessons: the Asian flu pandemic","volume":"59","author":"Jackson","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.vaccine.2026.128467_bb0670","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/bsp.2009.0729","article-title":"Public health and medical responses to the 1957-58 influenza pandemic","volume":"7","author":"Henderson","year":"2009","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.vaccine.2026.128467_bb0675","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.386515","article-title":"Panel urges wide use of antiviral drug","volume":"206","author":"Maugh","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128467_bb0680","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s13238-010-0025-y","article-title":"Flu channel drug resistance: a tale of two sites","volume":"1","author":"Pielak","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.vaccine.2026.128467_bb0685","article-title":"Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128467_bb0690","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128467_bb0695","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0264-410X(03)00067-7","article-title":"Animal influenza virus surveillance","volume":"21","author":"Fouchier","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128467_bb0700","article-title":"Floss-based vaccination targets the gingival sulcus for mucosal and systemic immunization","author":"RSJ","year":"2025","journal-title":"Nat Biomed Eng"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:54:35Z","timestamp":1781308475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":138,"alternative-id":["S0264410X26002756"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128467","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128467"}}